Share this page

Economic Burden of Non-medicinal Poisoning From Healthcare Provider Perspective in 2020: A Prevalence-Based Cost-of-Illness Study in Thailand mar

Kywel MH; Khiaocharoen O; Prasertworakul C; Khattiyod T; Youngkong S; Riewpaiboon A.
International Journal of Health Policy and Management 2026; 15(8928):- , 2026.

Impacts and Economic Burden of Pompe Disease on Patients and Families in Thailand: A Mixed Method Study

Youngkong S; Thavorncharoensap M; Chaikledkaew U; Luangsinsiri C; Tim-Aroon T; Kuptanon C; Sathienkijkanchai A; Rojnueangnit K; Wichajarn K; Boonyawat B; Suphapeetiporn K; Wattanasirichaigoon D.
ClinicoEconomics and Outcomes Research 2026; 18():1-11 , 2026.

Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand

Malasai K, Chaikledkaew U, Talungchit P, Youngkong S, Udomsinprasert W, Limwongse C, Jittikoon J.
Clin Transl Sci 2026 Jan 3 , 2026.

A comparison of health-related quality of life between continuous ambulatory peritoneal dialysis and automated peritoneal dialysis in children with stage 5 chronic kidney disease in Thailand: a randomized controlled trial

Thavorncharoensap M, Chaikledkaew U, Youngkong S, Assanatham M, Wisanuyotin S, Chaiyapak T, Pongwilairat N, Srisuwan K, Bhummichitra P, Pruangprasert P, Boonyapapong P, Chongchet N, Khongkhanin U, Vachvanichsanong P, Chartapisak W, Pattaragarn A.
Pediatric Nephrology 2025 Jan 20 , 2025.

Are Nutritional Interventions Worthwhile in Cancer Patients? A Systematic Review on Economic Evaluation

Nguyen HTT, Riewpaiboon A, Tran HTB, Youngkong S, Vo TQ, Turongkaravee S.
Clinicoecon Outcomes Res 2025 Dec 2;17:865-882 , 2025.

Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand

Malasai K, Jittikoon J, Udomsinprasert W, Talungchit P, Youngkong S, Sangroongruangsri S, Mahasirimongkol S, Chaikledkaew U.
Clinicoecon Outcomes Res 2025 Feb 4;17:33-43 , 2025.

Cost-Effectiveness Analysis of Different Prenatal Screening Strategies for the Prevention of Severe Thalassemia in Thailand

Malasai K, Jittikoon J, Talungchit P, Youngkong S, Udomsinprasert W, Chaikledkaew U.
Clinicoecon Outcomes Res 2025 Nov 15;17:835-848 , 2025.

Economic evaluation of automated peritoneal dialysis among pediatric patients with end state kidney diseases in Thailand

Assanatham M; Youngkong S; Thavorncharoensap M; Pattaragarn A; Chaikledkaew U.
Scientific Reports 2025 Mar 7 , 2025.

Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach

Chitpim N; Praditsitthikorn N; White LJ; Meeyai A; Jittikoon J; Bunwong K; Youngkong S; Thavorncharoensap M; Mahasirimongkol S; Udomsinprasert W; Chaikledkaew U.
PLoS ONE 2025 Feb 19;73(7):4288-4298 , 2025.

Economic evaluation of dialysis treatment in end-stage renal disease patients with fluid and sodium overload: Evidence from a randomized controlled trial in Thailand

Youngkong S, Yoopetch P, Thavorncharoensap M, Assanatham M, Chaikledkaew U, Sritippayawan S.
PLoS One 2025 Nov 15;17:835-848 , 2025.

Role of Health Equity in Health Technology Assessment Process in Asia: A Landscape Analysis of 13 Health Systems in Asia

Patikon C, Tan CJ, Cho JY, Khuntha S, Ha NT, Noviyani R, Gloria MAJ, Avanceña ALV, Youngkong S, Shimamoto K, Chaiyakunapruk N.
Value Health 2025 Feb 6:S1098-3015(25)00039-7 , 2025.

A systematic review and quality assessment of economic evaluations of kidney replacement therapies in end-stage kidney disease

Nyokabi P; Youngkong S; Bagepally BS; Okech T; Chaikledkaew U; McKay GJ; Attia J; Thakkinstian A.
Scientific Reports 2024; (23018):- , 2024.

Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey

Youngkong S, Kamolwat P, Wongrot P, Thavorncharoensap M, Chaikledkaew U, Nateniyom S, Pungrassami P, Praditsitthikorn N, Mahasirimongkol S, Jittikoon J, Nishikiori N, Baena IG, Yamanaka T.
Sci Rep 2024 May 16;14(1):11205 , 2024.

Correction to: A systematic review and quality assessment of economic evaluations of kidney replacement therapies in end-stage kidney disease (Scientific Reports, (2024), 14, 1, (23018), 10.1038/s41598-024-73735-8)

Nyokabi P; Youngkong S; Bagepally BS; Okech T; Chaikledkaew U; McKay GJ; Attia J; Thakkinstian A.
Scientific Reports 2024 Oct 10;7(11):3334-3357 , 2024.

Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis

Wattanasukchai L, Bubphan T, Thavorncharoensap M, Youngkong S, Chaikledkaew U, Thakkinstian A.
American Journal of Cardiovascular Drugs 2024 Nov 21 , 2024.

Cost-utility and budget impact analysis of neoadjuvant dual HER2 targeted therapy for HER2-positive breast cancer in Sri Lanka

Gunasekara ADM; Youngkong S; Anothaisintawee T; Dejthevaporn T; Fernandopulle R; Chaikledkaew U.
Scientific Reports 2024 Jun 28;83:56-65 , 2024.

Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand

Yoopetch P; Wu O; Jittikoon J; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Anothaisintawee T; Udomsinprasert W; Chaikledkaew U.
Scientific Reports 2024 May 28;15(7):2483-2495 , 2024.

Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study

Dewi PEN; Youngkong S; Sunantiwat M; Nathisuwan S; Thavorncharoensap M.
BMJ Open 2024 Oct 14;19:10341-10365 , 2024.

Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study

Dewi PEN; Sunantiwat M; Thavorncharoensap M; Youngkong S; Nathisuwan S; Rahajeng B.
PLoS ONE 2024; (e0302320):- , 2024.

Economic costs of alcohol consumption in Thailand, 2021

Luangsinsiri C; Youngkong S; Chaikledkaew U; Pattanaprateep O; Thavorncharoensap M.
Global Health Research and Policy 2023; 8(51):- , 2023.

Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: A systematic review and network meta-analysis

Aungsumart S, Youngkong S, Dejthevaporn C, Chaikledkaew U, Thadanipon K, Tansawet A, Khieukhajee J, Attia J, McKay G.J, Thakkinstian A.
Frontiers in Neurology , 2023.

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis

Yoopetch P, Anothaisintawee T, Gunasekara ADM, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Thakkinstian A, Chaikledkaew U.
Sci Rep 2023 Sep 27;13(1):16240 , 2023.

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis

Aungsumart S; Turongkaravee S; Youngkong S; Apiwattanakul M; Thakkinstian A; Chaikledkaew U.
BMC Health Services Research 2023 Nov 16;18(11):e0293866 , 2023.

Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds

Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, Youngkong S, Thakkinstian A, Chaiyakunapruk N, Ochalek J, Culyer AJ.
Expert Rev Pharmacoecon Outcomes Res 2023 Dec 19:1-13 , 2023.

Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study

Worakunphanich W, Suwankesawong W, Youngkong S, Thavorncharoensap M, Anderson C, Toh L.S.
International Journal of Clinical Pharmacy , 2023.

Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries

Worakunphanich W, Youngkong S, Suwankesawong W, Anderson C, Thavorncharoensap M.
International Journal of Environmental Research and Public Health 2022 May;43(9-10):939-954 , 2022.

Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi

Hezagira N, Youngkong S, Riewpaiboon A.
Int J Health Policy Manag 2022 May 23 , 2022.

Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi

Niyibitegeka F, Thavorncharoensap M, Riewpaiboon A, Youngkong S.
Appl Health Econ Health Policy 2022 Sep;20(5):707-716 , 2022.

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment

Yoopetch P, Chitpim N, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Praditsitthikorn N, Mahasirimongkol S, Chaikledkaew U.
International Journal of Environmental Research and Public Health 2022 May;43(9-10):939-954 , 2022.

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A.
BMJ Evid Based Med 2022 Aug;27(4):215-223 , 2022.

Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis

Gunasekara ADM, Anothaisintawee T, Youngkong S, Ha NT, McKay GJ, Attia J, Thakkinstian A.
Cancers (Basel) 2022 Jan 21;14(3):523 , 2022.

Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic

Kategeaw W, Youngkong S, Taychakhoonavudh S, Techathawat S, Chaiyakunapruk N.
Human Vaccines and Immunotherapeutics 2022 Dec 26;62(24):6508-6518 , 2022.

Priority setting of vaccine introduction in Bangladesh: A multicriteria decision analysis study

Haider MS, Youngkong S, Thavorncharoensap M, Thokala P.
BMJ Open 2022 May 23 , 2022.

A systematic review of demand-side methods of estimating the societal monetary value of health gain

Gloria MAJ, Thavorncharoensap M*, Chaikledkaew U, Youngkong S, Thakkinstian A, Culyer AJ..
Value in Health 2021; 24(10): 1423-1434., 2021.

Cost-utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in indian healthcare payer’s perspective

Bagepally BS, Chaikledkaew U*, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A..
ClinicoEconomics and Outcomes Research 2021; 13: 897-907., 2021.

Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi

Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M..
Vaccine 2021; 39(8) :1272-1282., 2021.

Economic burden of childhood diarrhea in Burundi

Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M..
Global Health Research and Policy 2021; 6(1): 13., 2021.

Knowledge, attitude and practice of traditional medicine-related adverse drug reaction (adr) reporting among hospital pharmacists and traditional medicine practitioners in Thailand

Worakunphanich W, Thongsombutpanitch F, Nilsonthi S, Youngkong S, Thavorncharoensap M*..
Pharmaceutical Sciences Asia 2021; 48(4): 330-338., 2021.

Safety of andrographis paniculata: A systematic review and meta-analysis

Worakunphanich W, Thavorncharoensap M*, Youngkong S, Thadanipon K, Thakkinstian A..
Pharmacoepidemiology and Drug Safety 2021; 30(6): 727-739., 2021.

Cost-effectiveness and resource allocation (CERA) 18 years of evolution: Maturity of adulthood and promise beyond tomorrow

Jakovljevic M*, Matter-Walstra K, Sugahara T, Sharma T, Reshetnikov V, Merrick J, Yamada T, Youngkong S, Rovira J..
Cost effectiveness and resource allocation 2020; 18(1): 15., 2020.

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: Systematic review and meta-analysis of economic evaluation studies

Bagepally BS, Chaikledkaew U*, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, McEvoy M, Attia J, Thakkinstian A..
BMJ open diabetes res care 2020; 8(1): e001020., 2020.

Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review

Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, Youngkong S, Rattanavipapong W, Meeyai A, Chaikledkaew U*..
Vaccine 2019; 37: A146-A153., 2019.

Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries

Haider S, Chaikledkaew U*, Thavorncharoensap M, Youngkong S, Islam MA, Thakkinstian A ..
Open Forum Infectious Diseases 2019; 6(4); ofz117., 2019.

The impact of transmission dynamics of rabies control: Systematic review

Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A*..
Vaccine 2019; A154-A165., 2019.

Treatment cost and costing model of obstetric complications at a hospital in Myanmar

Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S..
PLoS ONE 2019;14(3):e0213141, 2019.

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India

Dabak S.V, Pilasant S, Mehndiratta A, Downey L.E, Cluzeau F, Chalkidou K, Gonzales Luz A.C, Youngkong S, Teerawattananon Y..
Health Research Policy and Systems 2018; 16: 115, 2018.

Incorporating MCDA into HTA: Challenges and potential solutions, with a focus on lower income settings

Marsh K., Thokala P., Youngkong S., Chalkidou K..
Cost Effectiveness and Resource Allocation 2018; 16, 2018.

Development of a Health Screening Package under the Universal Health Coverage: The Role of Health Technology Assessment

Teerawattananon Y, Kingkaew P, Koopitakkajorn T, Youngkong S*, Tritasavit N, Srisuwan P, Tantivess S..
Health Economics 2016; 25: 162-178., 2016.

A cost function analysis of shigellosis in Thailand.

Riewpaiboon A, Youngkong S, Sreshthaputra N, Stewart JF, Samosornsuk S, Chaicumpa W, von Seidlein L, Clemens JD.
Value Health 2008;11 (Suppl 1) Mar: S75-S83., 2008.

Unit costs of medical services at Prasart Neurological Institute

Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W.
Srinakharinwirot J Pharm Sci 2004; 9(1): 52-8, 2004.

Cost of cerebral infarction in societal perspective

Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W..
Srinakharinwirot J Pharm Sci 2002; 7(1): 95-105, 2002.

Patient centered decision making: how multi-criteria decision analysis can help capture the patient voice.

Youngkong S*..
Health Technology Assessment International (HTAi) 2016 annual meeting. 10-14 may 2016 2016;, 2016.

Factor influencing physician’s decision on generic drug prescription: a case study of statin

Rodvanna P*, Anothaisintawee T, Youngkong S, Thavorncharoensap M..
Mahidol University Research Expo 2014 "MU Look to the Future" 1st - 2nd December 2014 , 2014.

Review of alcohol consumption trend, alcohol policies and contributions from key players in reducing alcohol consumption between 1997-2007 in Thailand.

Youngkong S, Yothasamut J, Teerawattananon Y, Thavorncharoensap M..
The ISPOR 3rd Asia Pacific conference, September 7-9, 2008, Seoul, Korea. 7-9 September 2008, Seoul, Korea., 2008.